This is what the technical report from Nueva EPS says about the death of Kevin Acosta, the boy who had hemophilia
The EPS affirms that it guaranteed prophylaxis for the minor's hemophilia and that the delay in the January dose occurred amid a portability process requested by the family. Photo: EL TIEMPO / Private Archive
TL;DR
- Nueva EPS asserts it provided prophylaxis for the child's hemophilia.
- A delay in a January dose is attributed to a portability process requested by the family.
- The information is based on the EPS's technical report.